Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is -4.67% vs 22.33% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -106.67% vs 12.88% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -60.16% vs 29.68% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 28.71% vs 44.54% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of Cuu Long Pharmaceutical JSC With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -13.01% vs 30.40% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -4.67% vs 22.33% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -144.22% vs 165.48% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -106.67% vs 12.88% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -15.26% vs 98.62% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -60.16% vs 29.68% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 3.69% vs -2.93% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 28.71% vs 44.54% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






